Researchers at Lund University have developed a new measuring technique to understand what happens to the neurons in rats’ brains when they are given psychedelics.
The final cohort of patients has been dosed in Cybin’s Dosing Phase 2 Trial investigating CYB003 – an investigational deuterated analogue of psilocybin – as a...
As hypothesised with cannabis, could the ‘entourage effect’ play a role in the therapeutic effects of psilocybin mushrooms?
A group of doctors are urging researchers to look at psychedelics to ease the often overwhelming distress faced by women with late-stage gynaecological cancers.
A donation of $1.5 million has been gifted to the UC San Diego Psychedelics and Health Research Initiative to research DMT by philanthropist Eugene Jhong.
Until now, it has been commonly thought that selective serotonin reuptake inhibitors (SSRIs) could interfere with the therapeutic potential of psilocybin treatment.
CEO of Cybin Inc.
New findings from an animal study show that psychedelics open a ‘critical period’ of social reward learning in the brain, but that different psychedelics do so...
Eleven major neuroscientific research projects related to “The Science of Perception Box” are being funded by the Tiny Blue Dot Foundation, each project receiving three consecutive...
A new report estimates that more than four million people in the Americas, Europe, Australia, and New Zealand have consumed ayahuasca at some point in their...
